SGLT2 Inhibitors—A Medical Revelation: Molecular Signaling of Canagliflozin Underlying Hypertension and Vascular Remodeling

Detalles Bibliográficos
Autores principales: Yagi, Takashi, Kolluru, Gopi K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375488/
https://www.ncbi.nlm.nih.gov/pubmed/35906180
http://dx.doi.org/10.1161/JAHA.122.026774
_version_ 1784767974490505216
author Yagi, Takashi
Kolluru, Gopi K.
author_facet Yagi, Takashi
Kolluru, Gopi K.
author_sort Yagi, Takashi
collection PubMed
description
format Online
Article
Text
id pubmed-9375488
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93754882022-08-17 SGLT2 Inhibitors—A Medical Revelation: Molecular Signaling of Canagliflozin Underlying Hypertension and Vascular Remodeling Yagi, Takashi Kolluru, Gopi K. J Am Heart Assoc Original Research John Wiley and Sons Inc. 2022-07-29 /pmc/articles/PMC9375488/ /pubmed/35906180 http://dx.doi.org/10.1161/JAHA.122.026774 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Yagi, Takashi
Kolluru, Gopi K.
SGLT2 Inhibitors—A Medical Revelation: Molecular Signaling of Canagliflozin Underlying Hypertension and Vascular Remodeling
title SGLT2 Inhibitors—A Medical Revelation: Molecular Signaling of Canagliflozin Underlying Hypertension and Vascular Remodeling
title_full SGLT2 Inhibitors—A Medical Revelation: Molecular Signaling of Canagliflozin Underlying Hypertension and Vascular Remodeling
title_fullStr SGLT2 Inhibitors—A Medical Revelation: Molecular Signaling of Canagliflozin Underlying Hypertension and Vascular Remodeling
title_full_unstemmed SGLT2 Inhibitors—A Medical Revelation: Molecular Signaling of Canagliflozin Underlying Hypertension and Vascular Remodeling
title_short SGLT2 Inhibitors—A Medical Revelation: Molecular Signaling of Canagliflozin Underlying Hypertension and Vascular Remodeling
title_sort sglt2 inhibitors—a medical revelation: molecular signaling of canagliflozin underlying hypertension and vascular remodeling
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375488/
https://www.ncbi.nlm.nih.gov/pubmed/35906180
http://dx.doi.org/10.1161/JAHA.122.026774
work_keys_str_mv AT yagitakashi sglt2inhibitorsamedicalrevelationmolecularsignalingofcanagliflozinunderlyinghypertensionandvascularremodeling
AT kollurugopik sglt2inhibitorsamedicalrevelationmolecularsignalingofcanagliflozinunderlyinghypertensionandvascularremodeling

Ejemplares similares